rs41276455
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_000720.4(CACNA1D):c.6349G>A(p.Asp2117Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000720.4 missense
Scores
Clinical Significance
Conservation
Publications
- aldosterone-producing adenoma with seizures and neurological abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- sinoatrial node dysfunction and deafnessInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1D | NM_000720.4 | c.6349G>A | p.Asp2117Asn | missense_variant | Exon 49 of 49 | ENST00000288139.11 | NP_000711.1 | |
| CACNA1D | NM_001128840.3 | c.6289G>A | p.Asp2097Asn | missense_variant | Exon 48 of 48 | ENST00000350061.11 | NP_001122312.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1D | ENST00000288139.11 | c.6349G>A | p.Asp2117Asn | missense_variant | Exon 49 of 49 | 1 | NM_000720.4 | ENSP00000288139.3 | ||
| CACNA1D | ENST00000350061.11 | c.6289G>A | p.Asp2097Asn | missense_variant | Exon 48 of 48 | 1 | NM_001128840.3 | ENSP00000288133.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152130Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251456 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461520Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727102 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74428 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 2117 of the CACNA1D protein (p.Asp2117Asn). This variant is present in population databases (rs41276455, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with CACNA1D-related conditions. ClinVar contains an entry for this variant (Variation ID: 504751). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
not specified Uncertain:1
The p.Asp2117Asn variant in CACNA1D has not been previously reported in individu als with hearing loss, but has been identified in 4/111704 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; d bSNP rs41276455). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational p rediction tools and conservation analyses do not provide strong support for or a gainst an impact to the protein. In summary, the clinical significance of the p. Asp2117Asn variant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at